Charles River Laboratories International (CRL) Gross Margin (2009 - 2026)

Charles River Laboratories International's Gross Margin history runs 17 years deep, the most recent figure standing at 182.51% for Q4 2025.

• In Q4 2025, Gross Margin rose 8658.0% year-over-year to 182.51%; the TTM figure through Dec 2025 stood at 110.66% (up 3168.0% YoY), while the FY2025 annual figure was 89.3%, down 151.0% from the prior year.
• Gross Margin for Q4 2025 stood at 182.51%, up from 89.06% in the prior quarter.
• The five-year high for Gross Margin was 262.47% in Q4 2023, with the low at 35.25% in Q3 2023.
• The 5-year median for Gross Margin is 89.74% (2021), against an average of 104.06%.
• The sharpest annual moves came in 2021 and 2024: Gross Margin surged 12111 bps in 2021, then plunged 16655 bps in 2024.
• Charles River Laboratories International's Gross Margin stood at 210.64% in 2021, then declined by 6 bps to 198.61% in 2022, then soared by 32 bps to 262.47% in 2023, then tumbled by 63 bps to 95.92% in 2024, then jumped by 90 bps to 182.51% in 2025.
• Business Quant data shows CRL's Gross Margin at 182.51% in Q4 2025, 89.06% in Q3 2025, and 86.13% in Q2 2025.